Objective: To study the lipoprotein distribution of supplemented coenzyme Q 10 (CoQ 10 ), vitamin E, and polyunsaturated fatty acids (PUFA). Design: Balanced three-period crossover study. Setting: University research unit. Subjects: Eighteen apparently healthy free-living non-smoking volunteers (nine women, nine men), mean age 26 AE 3 y, recruited among the university students; no dropouts. Interventions: Three supplementation periods of 10 days: 100 mgaday CoQ 10 , 350 mgaday D-a-tocopherol, and 2 gaday concentrated ®sh oil. Fasting venous blood samples were collected twice before the ®rst period and then after each period. Plasma and isolated lipoproteins were analysed for cholesterol, triacylglycerol, a-and g-tocopherol, CoQ 10 , and fatty acid composition. Results: Signi®cant (P`0.05) increase in CoQ 10 and a-tocopherol occurred in all lipoprotein classes after supplementation. CoQ 10 was primarily incorporated into low-density lipoprotein (LDL). a-tocopherol and ®sh oil n-3 PUFAs had similar patterns. They were equally distributed between LDL and high-density lipoprotein (HDL), with a smaller part in VLDL. The total sum of PUFA was unchanged following all supplementations, but ®sh oil increased the amount of n-3 fatty acids at the expense of n-6 fatty acids. Conclusion: Lipoprotein distribution of CoQ 10 is markedly different from that of a-tocopherol, suggesting that they may be metabolised by distinct routes. a-Tocopherol is distributed similarly to n-3 fatty acids, thus providing protection on location for the oxidatively labile PUFAs.
Introduction
The antioxidative status of human beings and its in¯uence on health aspects remain a subject of debate. Delay or even prevention of a wide spectrum of degenerative disorders may be closely related to the body content of certain antioxidants. This complex of problems has called for a reevaluation of the recommended daily intake of antioxidants and vitamins. Existing nutritional recommendations are based on prevention of de®ciency symptoms. However, in order to achieve therapeutic and pharmacological effects of antioxidants and vitamins we may need to administer larger doses than so far recommended. Furthermore, to comply with individual requirements, improved knowledge of speci®c effects of antioxidants and their interactions with other nutrients is necessary.
Atherosclerosis is the major cause of death in most industrialized countries. Over the years, the relationship between development of this disease and interaction of antioxidantsaoxidants and lipids in the blood vessels and circulation has remained a subject of extensive research (Spranger et al, 1998; Jialal & Devaraj, 1996; Kontush et al, 1994; Fuller & Jialal, 1994) . It is believed that the amount and compositiosn of dietary fat are major risk factors. Considerable interest is directed towards the in¯uence of lipoprotein metabolism and composition because of its important part in the transport and distribution of dietary fat. Oxidative modi®cation of low-density lipoprotein (LDL) in the arterial wall is assumed to contribute signi®-cantly to the initiation of atherosclerosis (Daugherty & Roselaar, 1995) . LDL is the main transport vehicle for cholesterol and accumulation of cholesterol in oxidized LDL particles causes foam cell formation followed by increased atherogenicity (Fruchart & Duriez, 1994) .
Intake of unsaturated fat at the expense of saturated fat has been shown to reduce the level of cholesterol and triacylglycerol in LDL and to a smaller extent in high-density lipoprotein (HDL) (Nelson et al, 1997; Lees, 1990) . However, in addition to this bene®cial effect on the plasma lipid level, polyunsaturated fatty acids (PUFAs) may be vulnerable to oxidation during their lipoprotein transport . As such, oxidizability may depend greatly on the amount of PUFA within the lipoprotein particles, and increase the demand for antioxidants. The protective role of lipophilic antioxidants appears to be mediated in part by their capacity to increase the oxidative resistance of PUFA when transported to the lipoproteins (Tertov et al, 1998; Kontush et al, 1994; Oostenbrug et al, 1994) .
Much research has been focused on antioxidants present in LDL. However, the antioxidative status and metabolism of HDL and very low-density lipoprotein (VLDL) may also be important (Banka, 1996; Mohr & Stocker, 1994) . The quantitatively most important antioxidant in the lipoproteins is a-tocopherol. However, coenzyme Q 10 (CoQ 10 ), has in addition to its classical role as an electron carrier in the mitochondrial respiratory chain recently gained much attention as a potential antioxidant in plasma and lipoproteins (Bowry et al, 1995; Mohr et al, 1992) . The antioxidative function of CoQ 10 has been suggested to be either as a chain-breaking antioxidant or via regeneration of a-tocopherol (Ernster, 1994) , but in either case it has an in¯uence on the function of vitamin E (Thomas et al, 1996; Stocker et al, 1991) . In contrast to the vitamin E isomers, CoQ 10 is endogenously synthesized in addition to the dietary intake. It is therefore interesting to compare the transport characteristics of these chemically related antioxidants, as it presently is unknown to what extent dietary CoQ 10 contributes to the lipoprotein CoQ 10 pool.
Dietary supplements of vitamin E and CoQ 10 are popular among the population, as well as supplements of ®sh oil containing high amounts of n-3 PUFA. Little is presently known regarding the transport pattern and distribution within the lipoprotein classes of these supplements. The aim of the present study was to elucidate the molecular organization within the lipoprotein classes of CoQ 10 and atocopherol obtained by dietary supplements, in order to achieve a better understanding of the transport kinetics and antioxidative properties of those components. In order to function optimally, the lipoprotein antioxidants have to be present along with the oxidatively labile PUFAs. To evaluate this potential, the distribution pattern of the antioxidants was compared to the lipoprotein distribution of a ®sh oil supplement, containing a high proportion of oxidatively labile PUFAs. In addition, we compared the lipoprotein distribution of supplemented a-tocopherol and CoQ 10 to evaluate their potential interactions.
Methods

Subjects
Eighteen healthy non-smoking volunteeres (nine males and nine females, 26 AE 3 y, body mass index 22.9 AE 1.7 kgam 2 ) were enrolled. The subjects had no limitations in living and food habits during the experiment, except they were asked to avoid intake of extra vitamins. They received no medication (except contraceptives) and were asked to refrain from consuming alcohol the day before blood sampling, and not to eat from the previous evening. The subjects were instructed to ingest the supplements with a meal, meaning that the last dose of antioxidants typically was ingested 14 h before the blood sampling. The trial was approved by The Ethical Committee of Copenhangen, and all participants gave written informed consent. All subjects completed the study.
Study design
The study was a balanced three-period crossover study. In addition to their habitual diet the subjects received supplements of CoQ 10 (100 mgaday Bio-Qinon Q10), D-a-tocopherol (350 mgaday Bio-E-Vitamin), and concentrated ®sh oil (4 Â 500 mgaday Bio-Marin), furnishing a total of 1330 mgaday n-3 fatty acids (of these 35% 20:5 n-3 (EPA) and 25% 22:6 n-3 (DHA)), and 10 mg D-a-tocopherol added as an antioxidant. All supplements were kindly donated by Pharma Nord ApS, Denmark, and were given for 10 days each, followed by an 18 day washout period.
Blood sampling
Blood sampling was performed twice before the ®rst supplementation period, and then after each period. Fasting venous blood samples (40 ml) were collected into sterile evacuated centrifuge tubes containing K 3 EDTA (Venoject 1 , VT-100TK, Terumo Europe, Belgium). Plasma was then immediately isolated by centrifugation (1000 g, 20 min). Of this, 3 ml was used for lipoprotein fractionation and the remaining plasma was stored at 7 80 C within 1 h after collection.
Isolation of lipoproteins
Lipoproteins were fractionated based on their hydrated density by discontinuous KBr gradient ultracentrifugation for 22 h at 10 C (Dieber-Rotheneder et al, 1991) . Fractions of 0.4 ml were collected successively downwards from the meniscus of the tube. The fractions containing VLDL (1 ± 2), LDL (8 ± 11) and HDL (16 ± 19) were pooled and dialyzed overnight at 4 C against a buffer containing 0.15 M NaCl and 1 mM Na 2 -EDTA (pH 8). The dialyzed lipoprotein classes were stored at 7 80 C until analysis. Prior to initiation of the experiment the purity of the obtained lipoprotein fractions was veri®ed by crossed immuno-agarose gelelectrophoresis with speci®c antibodies.
Cholesterol and triacylglycerol analyses
The automated assays of total cholesterol and triacylglycerol in plasma and lipoprotein classes were carried out on a 
Antioxidant analyses
Plasma and lipoprotein samples were analysed for the content of CoQ 10 , a-and g-tocopherol by reversed-phase HPLC with electrochemical detection, essentially as described by Andreassen et al (1999) , except for using HClO 4 in the mobile phase (1.2 mlamin methanolaethanola 2-propanol 36:53:11 volavolavol containing 6.8 mM LiClO 4 and 1.4 mM HClO 4 ). All solvents were HPLC-grade. Quanti®cation was carried out by comparing peak areas to the area of standard curves obtained with authentic compounds (a-tocopherol, CoQ 9 and CoQ 10 , all obtained from Sigma). a-Tocopherol was used as standard for g-tocopherol quanti®cation as well, as they have similar response curves. Correction of losses during extraction for all antioxidants was calculated using the recovery of the internal standard, CoQ 9 .
Fatty acid pro®le. The fatty acid pro®le of the lipoprotein classes was determined by gas ± liquid chromatography (GLC) with¯ame-ionization detector (FID). Lipids were extracted from lipoprotein classes as follows. Internal standard solution containing 100.4 mgal hepatadecanoic acid in chloroform was added to a 300 ml sample, followed by extraction with 4.0 ml chloroform:methanol 1:1 (volavol). After centrifugation (1000 g, 10 min) the supernatant was removed and evaporated to dryness under a stream of nitrogen. Methyl esters were prepared by transmethylation catalysed by BF 3 (Hùy & Hùlmer, 1988) . After extraction with 5.0 ml heptane the fatty acid methyl esters were analysed by GLC on a Hewlett-Packard 6890 instrument (Palo Alto, California) in the split mode with a CPSil88 capillary column (50 m Â 0.25 mm i.d., 0.2 mm ®lm, Chrompak). The initial oven temperature was 150 C. The temperature was raised to 220 C at 4 Camin and then held constant for 4.5 min. The initial pressure of the carrier gas (He) was 33 psi.
Statistics
All statistical analyses were performed using Jandel SigmaStat Statistical Software Version 2.0. Results were expressed as mean AE standard error of the mean (s.e.m.) and subjected to a two-way analysis of variance (ANOVA) using a repeated measurements model with the variables subject (repeated), supplement and sample type. A P-valule of less than 0.05 was considered signi®cant. Some ®gures or tables represent data from less than 18 subjects due to loss of lipoprotein samples during preparation and analysis.
Results
Ten days of supplementation with 100 mgaday CoQ 10 increased total CoQ 10 levels in plasma by 126% as compared with the baseline level (Table 1) . Correspondingly, 350 mgaday D-a-tocopherol supplementation elevated atocopherol concentration in plasma by 92%, whereas g-tocopherol levels diminished by 44%. A small but signi®cant increase (13%) in plasma a-tocopherol concentration was observed as a result of ®sh oil supplementation, probably caused by the low additional a-tocopherol (10 mgaday) in the ®sh oil capsules. Neither plasma total cholesterol nor plasma triacylglycerol changed signi®cantly after the supplementations.
The changes in plasma antioxidant composition upon supplementation were markedly re¯ected in the lipoproteins. Intake of CoQ 10 for 10 days more than doubled the concentration of CoQ 10 in VLDL, LDL and HDL, whereas no change in CoQ 10 was observed after supplementation with neither a-tocopherol nor ®sh oil ( Figure 1a) . a-Tocopherol supplementation signi®cantly elevated the concentration in all the lipoprotein classes ( Figure 1b) . The small increase in plasma a-tocopherol after ®sh oil intake was re¯ected in the HDL fraction only. The reduction in plasma g-tocopherol concentration after a-tocopherol supplementation was re¯ected in LDL and HDL, but not in VLDL (Figure 1c) .
To compare the transport characteristics of the supplied antioxidants and ®sh oil PUFAs, the percentage distribution within lipoprotein classes was calculated at baseline and after supplementation (Figure 2a and b) . At baseline, CoQ 10 is preferentially transported in LDL (64%), with the remaining part is primarily located in HDL (26%), whereas 
*P`0X05, supplement vs baseline, n 16.
a Vitamin E supplements contain exclusively D-a-tocopherol.
Lipophilic antioxidants and PUFAs V Hougaard Sunesen et al a-tocopherol was more equally distributed between LDL (52%) and HDL (39%) with a minor fraction transported by VLDL (8%) (Figure 2a ). The majority of baseline 22:6 n-3 (DHA) and 20:5 n-3 (EPA) PUFAs are located in HDL (53%), in accordance with the high amount of PUFAs in phospholipids, with the remaining part primarily in LDL (37%) and 10% in VLDL. The distribution pattern is signi®cantly different for each of the three dietary supplements (P`0.001). After supplementation, the distribution pattern overall resembles the baseline situation, except for a larger proportion of a-tocopherol (20%) and DHA EPA (24%) in VLDL (Figure 2b) . The distribution pattern of CoQ 10 differs signi®cantly from that of a-tocopherol (P`0.001), whereas the distribution of supplemented a-tocopherol and PUFAs are similar.
Following 10 days of ®sh oil supplementation a 50 ± 60% elevation in n-3 fatty acids was observed in all lipoprotein classes (Figure 3a) . In contrast to the pattern of n-3 fatty acids, the total amount of PUFA (n-3 and n-6 fatty acids) was not signi®cantly altered after consumption of ®sh oil (Figure 3b ). The total level of PUFA in HDL and LDL was maintained around 45% of fatty acids, and in VLDL around 28% of fatty acids, a difference mainly due to different content of phospholipids in the lipoprotein classes.
The lipoprotein particle content of CoQ 10 , a-and g-tocopherol, and PUFA double bonds were calculated (Table 2) , based on the average content of cholesterol in lipoprotein particles as recorded by Shen et al (1977) . A distinct progressive increase in antioxidants as well as in PUFA double bonds was observed with increased molecular size of the lipoproteins. a-Tocopherol is the quantitatively dominating lipophilic antioxidant in the lipoproteins, illustrated by the 20 ± 40 times higher content of a-tocopherol comapared to CoQ 10 and gtocopherol. At baseline the distribution pattern of g-tocopherol resembled that of a-tocopherol.
Following supplementation, the particle content of CoQ 10 increased in the order of 250% in all lipoprotein classes: 230% in HDL, 260% in LDL and 293% in VLDL. a-tocopherol increased most markedly in VLDL (260%), whereas LDL and HDL showed much less distinct changes (93 and 56%, respectively; Table 2 ).
The amount of n-3 PUFAs (DHA EPA)aparticle increased signi®cantly in all lipoprotein classes upon ®sh oil supplementation. The content of PUFA double bondsaparticle was calculated as a marker for fatty acid unsaturation and oxidizability, and did not re¯ect the ®sh oil supplementation signi®cantly.
To evaluate the potential protection of the individual PUFAs, the number of antioxidantadouble bonds was calculated. One CoQ 10 molecule occurred among 11 000 double bonds in VLDL, 8000 in LDL and 40 000 in HDL at baseline. Correspondingly, one a-tocopherol molecule at baseline was present among 500 double bonds in VLDL, 350 in LDL, and 900 in HDL. For both antioxidants, the LDL lipoprotein class showed the highest ratio of antioxidantsadouble bonds.
Discussion
A better understanding of the protective role of dietary antioxidants within lipoproteins requires information on Figure 1 Lipoprotein concentration (mM in plasma) of (a) coenzyme Q 10 , (b) a-tocopherol, and (c) g-tocopherol following supplementation with coenzyme Q 10 , vitamin E, and ®sh oil in healthy volunteers (mean AE s.e.m., n 16). *P`0.05, supplementation vs baseline.
Lipophilic antioxidants and PUFAs
V Hougaard Sunesen et al their metabolism and distribution. a-Tocopherol is well known as the major lipophilic antioxidant in plasma and lipoproteins (Kayden & Traber, 1993) , but it has also been observed to function as a pro-oxidant in absence of regenerating substances (Stocker & Bowry, 1996) . CoQ 10 has been suggested as a potent co-antioxidant for a-tocopherol (Bowry et al, 1995; Stocker et al, 1991) . In order to protect the lipoproteins against oxidation, the antioxidants have to be present along with the PUFAs that are most vulnerable towards oxidation. Also, in order to function together as an antioxidant and co-antioxidant pair, a-tocopherol and CoQ 10 have to be present within the same lipid phases. In the present study, we investigated the lipoprotein distribution of dietary supplements of a typical commercially recommended dose of CoQ 10 , a-tocopherol and ®sh oil PUFAs in healthy subjects. The dietary supplements all induced signi®cant change in the plasma and lipoprotein concentration of the individual supplements. The CoQ 10 supplement induced a larger relative increase in the plasma concentration (125%) than the atocopherol supplement (92%), although the molar quantity of the ingested a-tocopherol (777 mmoladay) was larger than that of CoQ 10 (116 mmoladay).
The baseline plasma concentrations of CoQ 10 (1.08 AE 0.10 mM) and g-tocopherol (1.35 AE 0.11 mM) were in the range of similar studies (Perugini et al, 2000a ; Figure 2 Lipoprotein distribution of (a) coenzyme Q 10 , a-tocopherol, and n-3 PUFAs at baseline, and (b) following supplementation with coenzyme Q 10 , a-tocopherol, and ®sh oil in healthy volunteers (mean AE s.e.m.). Columns with different letters differ signi®cantly (P`0.05).
Lipophilic antioxidants and PUFAs V Hougaard Sunesen et al Tomasetti et al, 1999; Goulinet & Chapman, 1997; Folkers et al, 1994) , whereas a-tocopherol levels (33.3 AE 2.31 mM) were slightly higher than described in the literature (15.7 ± 32.3 mM; Perugini et al, 2000a; Tomasetti et al, 1999; Kontush et al, 1999; Goulinet & Chapman, 1997) . Surprisingly, the ®sh oil supplementation resulted in a small but signi®cant increase in the plasma a-tocopherol concentration (13%), presumably due to the low amount of atocopherol added to the ®sh oil capsules (10 mgaday). As compared to the 350 mg supplementation, this low amount is negligible, but it is in the range of the average Danish dietary intake (approximately 7 mg a-tocopheroladay (Weber et al, 1996) ), and thereby not unlikely to affect plasma levels. The observed increase in a-tocopherol following ®sh oil intake opposed to the presumption that the PUFAs contained in the ®sh oil potentially could cause oxidation and decrease the a-tocopherol. a-tocopherol consumption resulted in a signi®cant decrease in g-tocopherol concentration, which could be due to discrimination against g-tocopherol in favour of a-tocopherol during absorption and hepatic VLDL assembly, as described by Traber et al (1992) .
Numerous other studies have shown decreases in the plasma triacylglycerol levels following ®sh oil consumption, but such an effect was not seen in this study. Plasma cholesterol and triacylglycerol levels were within the nor- Figure 3 Lipoprotein fatty acid composition of (a) total n-3 fatty acids and (b) total amount of PUFAs following supplementation with coenzyme Q 10 , a tocopherol, and ®sh oil in healthy volunteers (mean AE s.e.m., n 14). *P`0.05, supplement vs baseline.
V Hougaard Sunesen et al molipidemic range, and remained constant throughout the study. The supplementation period (10 days) was chosen to ascertain steady state with regard to the lipoprotein composition (lipoprotein half-lives are in the range of hours), and it is possible that the triacylglycerol lowering effect would have appeared after a longer supplementation period, or a larger dose than 2 gaday. However, another study similarly showed constant triacylglycerol levels using a higher dose of ®sh oil (5 gaday EPA and DHA) and a longer period (6 weeks) (Brude et al, 1997) . As expected, the lipoprotein pattern re¯ected the plasma concentrations. Supplementation with CoQ 10 and a-tocopherol was followed by signi®cant increases in all lipoprotein classes. Lipoprotein levels of CoQ 10 were more than doubled, and a-tocopherol concentration was nearly doubled. These considerable increases indicate that saturated plasma lipoprotein levels of CoQ 10 and a-tocopherol were far from being reached with dietary intake as the only source of those two antioxidants. Like Weber et al (1994), we did not observe any sparing effect of CoQ 10 on atocopherol.
The ®sh oil consumption signi®cantly increased the content of n-3 fatty acids in all lipoprotein classes. However, this increase was apparently compensated for by a corresponding decrease in n-6 fatty acids, as the sum of PUFAs remains unchanged, indicating a homeostatic regulatory mechanism in the assembly and metabolism of the lipoproteins. The sum of PUFA double bonds was used as a marker for oxidizability of the PUFAs, and did not change upon ®sh oil administration. Although neither the sum of PUFA nor the sum of double bonds changed, some changes in the oxidizability may still have occurred, since the ®sh oil PUFAs are highly unsaturated, and the tendency of fatty acids towards oxidation increases exponentially with increasing number of double bonds, rather than linearly. Still, the increase in a-tocopherol level during ®sh oil consumption shows that no extensive oxidation has taken place and that the ®sh oil supplement seems suf®ciently protected against oxidation.
To evaluate the transport characteristics of the supplemented antioxidants and PUFAs their distribution was compared to baseline levels. CoQ 10 showed a very similar pattern between baseline (10a64a26% in VLDLa LDLaHDL, respectively) and supplements (9a68a23%), suggesting that the metabolism of supplements resembles that of dietary and endogeneous CoQ 10 . The baseline ®gures are in accordance with the existing reports on CoQ 10 lipoprotein distribution. Tomasetti et al (1999) found 16a58a26% in VLDLaLDLaHDL of 44 healthy subjects, and Johansen et al (1991) found 75% in VLDL LDL and 25% in HDL from 23 healthy males, whereas Alleva et al (1997) in a group of 44 subjects found 56% in LDL and 22% in HDL for males, and 61% and 29% for females. None of the above studies investigated the distribution of supplemented CoQ 10 .
a-Tocopherol and n-3 PUFAs show a quite similar distribution pattern following supplementation, with the main part in HDL, demonstrating that a-tocopherol provides protection on location for the oxidatively labile PUFAs. This observation is in accordance with Pronczuk et al (1991) , who concluded that a-tocopherol is preferentially located close to the PUFAs in the hydrophobic region of the phospholipid bilayer.
A higher proportion of the supplemented a-tocopherol and n-3 PUFAs (21 and 24%, respectively) were found in VLDL compared to baseline (8 and 10%, respectively). The 
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Content of cholesterol in lipoprotein particles employed for the calculations is 7139 molamol VLDL particle, 1785 molamol LDL particle, and 65 molamol HDL particle (Shen et al, 1977) . *P`0X05, supplement vs baseline.
a Vitamin E supplements contained D-a-tocopherol. b EPA and DHA C20:5 n-3 and C22:6 n-3 PUFAs.
Lipophilic antioxidants and PUFAs V Hougaard Sunesen et al distribution for a-tocopherol and n-3 PUFAs, respectively, was 8a52a40 and 10a37a53 in VLDLaLDLaHDL at baseline, vs 21a38a41 and 24a33a43 following supplementation. The a-tocopherol baseline values are in accordance with Johansen et al (1991) , who found 52a48% in (VLDL LDL)aHDL, whereas Tomasetti et al (1999) only found 28% in HDL (31a41a28% in`other lipoproteins'aLDLaHDL, and Perugini et al (2000b) found 21a37a42 in VLDLaLDLaHDL. The observed differences between the above-mentioned studies could (at least partly) be due to dietary differences between the Scandinavian countries (Denmark and Sweden) and Italy. The antioxidants CoQ 10 and a-tocopherol are both transported within the lipoproteins, and have very similar physico-chemical properties, and it was assumed a priori that their lipoprotein distribution would be similar. Contrary to this assumption, a-tocopherol and CoQ 10 show very distinctly different distribution patterns. The preferential CoQ 10 enrichment of LDL may support the hypothesis that CoQ 10 primarily functions as an antioxidant in LDL during initial events of the lipid peroxidation, and is oxidized before a-tocopherol, which exerts prooxidant rather than antioxidant effects in this phase (Kontush et al, 1994; Stocker et al, 1991) .
The higher proportion of PUFAs and a-tocopherol in VLDL compared to CoQ 10 suggests that the liver actively incorporates a-tocopherol and PUFAs into VLDL and discriminates against CoQ 10 in this process. This difference has physiological relevance, and merits further investigation.
To evaluate effects of the supplementations within the lipoprotein particles, the lipoprotein particle content of CoQ 10 , a-and g-tocopherol, and PUFA double bonds were calculated, based on the average content of cholesterol in lipoprotein particles as recorded by Shen et al (1977) . The calculated data, based on cholesterol measurements, were consistent with data calculated on basis of triacylglycerol measurements (data not shown). The CoQ 10 content in LDL (0.34 CoQ 10 moleculesaLDL) is slightly lower than previous reports, ranging from 0.5 to 0.8 CoQ 10 aLDL (0.54 CoQ 10 aLDL (Kontush et al, 1994) , 0.5 ± 0.8 CoQ 10 aLDL (Thomas et al, 1996) , and 0.6 CoQ 10 aLDL (Karlsson et al, 1993) ). Similarly, the particle content of a-tocopherol in the lipoproteins (69 molecules a-tocopherolaVLDL, 7.2aLDL and 0.40aHDL) is rather consistent with available data (39 a-tocopherolaVLDL, 8.5aLDL and 0.58aHDL; Goulinet & Chapman, 1997) .
Oxidative modi®cation of PUFAs may be delayed or even avoided in the presence of lipophilic antioxidants (Stocker, 1994; Buettner, 1993; Krinsky, 1992) . The oxidative lability of PUFA increases proportionally with increased unsaturation of the fatty acids (Cosgrove et al, 1987) . Using the amount of PUFA double bonds as a marker for oxidative lability within lipoprotein fractions, our data demonstrates that LDL particles are best protected, as they have the highest antioxidantadouble bond ratio. This could re¯ect a larger need for protection within this potentially atherogenic component. This protection persisted even after signi®cant compositional changes within lipoproteins due to n-3 from ®sh oil consumption. Biesalski et al (1997) proposed an optimal plasma concentration of a-tocopherol around 30 mM as an indicator of adequate antioxidant intake, and a measure of primary prevention of coronary heart disease. This criterion was ful®lled in the population studied, even before supplementation with a-tocopherol, and persisted during consumption of oxidatively labile n-3 fatty acids from ®sh oil. Accordingly, we conclude that the ®sh oil supplement is suf®ciently protected against oxidation.
The present study provides information on the distribution and transport patterns of the dietary supplemented antioxidants CoQ 10 and a-tocopherol, as well as the oxidatively labile n-3 PUFAs from ®sh oil supplementation. Our results suggest that CoQ 10 and a-tocopherol are metabolised by different routes. Dietary supplementation of 100 mgaday CoQ 10 for 10 days was followed by signi®cant increases in all lipoprotein classes, CoQ 10 being primarily incorporated into LDL. Ingestion of 350 mgaday a-tocopherol for 10 days caused signi®cant increases in all lipoprotein classes, with the major part of a-tocopherol distributed in HDL, less in LDL and even less in VLDL. Following dietary supplementation of 2 gaday concentrated ®sh oil for 10 days we observed a signi®cant increase in n-3 fatty acids but no overall alteration of the total amount of PUFA. Fish oil ingestion caused no reduction in the plasma levels of triacylglycerol or cholesterol and had no in¯uence on the content of antioxidants in the lipoproteins. On a per particle basis, PUFA double bonds within LDL were better protected by CoQ 10 and a-tocopherol than the ones within VLDL and HDL. In conclusion, dietary supplementation with CoQ 10 , a-tocopherol and ®sh oil in the ingested quantities is apparently safe with regard to interactions and alteration of the level of available substrate for lipid peroxidation.
